Related Experiment Video
Updated: Apr 14, 2026

09:35
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
18.5K
A meta-analysis strategy for gene prioritization using gene expression, SNP genotype, and eQTL data.
1Bio-Intelligence & Data Mining Lab, School of Electronics Engineering, Kyungpook National University, 1370 Sankyuk-dong, Buk-gu, Daegu 702-701, Republic of Korea.
Biomed Research International
|April 16, 2015
Summary
This study introduces a novel meta-analysis strategy to prioritize disease-related genes by integrating gene expression, SNP genotype, and eQTL data. The approach improves accuracy in identifying significant genes for human diseases like cancer.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Identifying genes crucial to human disease pathogenesis is essential for medical advancements.
- Previous gene prioritization methods using gene expression or SNP data often yield numerous false positives.
Purpose of the Study:
- To develop an integrative meta-analysis strategy for robust gene prioritization.
- To enhance the identification of significant disease-related genes by combining multiple genetic data types.
Main Methods:
- A meta-analysis strategy integrating gene expression, single nucleotide polymorphism (SNP) genotype, and expression quantitative trait loci (eQTL) data.
- Utilized an improved Technique for the Order of Preference by Similarity to Ideal Solution (TOPSIS) for data integration and scoring.
Main Results:
- The proposed strategy demonstrated superior performance compared to conventional methods in identifying disease-related genes.
- Successfully identified significant genes for prostate and lung cancer using integrated genetic resources.
- Effectively leveraged the complementary information from diverse genetic datasets.
Conclusions:
- The integrative meta-analysis approach offers a more accurate and reliable method for gene prioritization in human diseases.
- This strategy holds promise for improving disease diagnosis and discovering novel drug targets.

